Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 49.49 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 59.04 | Oscillator | Neutral |
| Williams %R (14) | -55.84 | Oscillator | Neutral |
| MACD (12, 26, 9) | 0.03 (Hist 0.03) | Oscillator | Strong Buy |
| Average Directional Index (14) | 16.38 (+DI 17.2 / -DI 20.2) | Trend | Neutral |
Current price $6.02
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Sep 17, 26 |
| EMA 20 | 6.02 | MA | Sell |
| SMA 20 | 5.96 | MA | Buy |
| EMA 50 | 6.38 | MA | Strong Sell |
| SMA 50 | 5.86 | MA | Buy |
| SMA 200 | 9.31 | MA | Strong Sell |
| Baird |
| maintain |
| Outperform |
| Outperform |
| Aug 6, 26 | RBC Capital | maintain | Outperform | Outperform |
| Aug 6, 26 | UBS | maintain | Buy | Buy |
| Aug 5, 26 | Truist Securities | maintain | Buy | Buy |
| Jul 21, 26 | Jefferies | upgrade | Hold | Buy |
| Jul 6, 26 | Baird | maintain | Outperform | Outperform |
| May 11, 26 | RBC Capital | maintain | Outperform | Outperform |
| May 6, 26 | UBS | maintain | Buy | Buy |
| May 6, 26 | Canaccord Genuity | maintain | Buy | Buy |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Sep 9, 26 | Currie Harriss T | officer: CHIEF FINANCIAL OFFICER | A-Award | 141,372 | — |
| Sep 9, 26 | Currie Harriss T | officer: CHIEF FINANCIAL OFFICER | 0 | — | |
| Aug 6, 26 | Wolf Dale B | director | P-Purchase | 20,000 @ $6.30 | $126.0K |
| Aug 6, 26 | Samet Kenneth A | director | P-Purchase | 23,500 @ $6.38 | $149.9K |
| Aug 6, 26 | Wolf Dale B | director | P-Purchase | 20,000 @ $6.37 | $127.4K |
| Aug 7, 26 | Wolf Dale B | director | P-Purchase | 20,000 @ $5.86 | $117.2K |
| Jul 1, 26 | Schuster Iii Russell E. | officer: Chief Commercial Officer | S-Sale | 11,275 @ $10.44 | $117.7K |
| Jun 24, 26 | Williams David Solomon Iii | director | A-Award | 18,999 | — |
Stock news · updated daily
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its third quarter 2026 financial results before the opening of the financial markets on Tuesday, November 3, 2026. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts a.
AdaptHealth (NASDAQ: AHCO - Get Free Report) and Precipio (NASDAQ: PRPO - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, valuation, institutional ownership, profitability, analyst recommendations and dividends. Analyst Recommendations This is a summary of current ratings
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | 0.17 | 0.06 | Miss -64.5% | $740.3M |
| May 5, 2026 | 0.01 | -0.06 | Miss -580.0% | $819.8M |
| Feb 24, 2026 | 0.34 | 0.27 | Miss -20.6% | $846.3M |
| Nov 4, 2025 | 0.24 | 0.22 | Miss -8.3% | $820.3M |
| Aug 5, 2025 | 0.15 | 0.01 | Miss -93.3% | $800.4M |
| May 6, 2025 | 0.01 | 0.01 | Beat 0.0% | $777.9M |
FY2025 · 10-K disclosure
TTM vs. 5-year historical average (annual ratios)
| Metric | AHCO | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -3.6x | 10.7x · sector 20.7x | Discount |
| Forward P/E (FY26E) | -29.7x | EPS est. -0.20 | Elevated |
| Price / Book | 0.6x | 1.0x | Discount |
| Price / Sales | 0.3x | 0.6x | Discount |
| EV / EBITDA | 9.8x | 2.3x | Elevated |
| Return on equity | -15.2% | — | Weak |
| Gross margin | 10.4% | 18.4% | Below hist. |
| Debt / Equity | 1.50 | 1.28 | Moderate |
| Piotroski / Altman Z | 5/9 | Z 0.52 | Distress |
Discounted cash flow model
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| SC 13G/A | Oct 13, 2026 | 2026-10-13 11:57:51 | View |
| SC 13G/A | Oct 8, 2026 | 2026-10-08 14:25:41 | View |
| 4 | Sep 11, 2026 | 2026-09-11 16:11:36 | View |
| 3 | Sep 11, 2026 | 2026-09-11 16:10:22 | View |
| 8-K | Sep 8, 2026 | 2026-09-08 16:16:29 | View |
| 4/A | Aug 14, 2026 | 2026-08-14 16:01:15 | View |
| 4 | Aug 10, 2026 | 2026-08-10 20:03:18 | View |
| 4 | Aug 10, 2026 | 2026-08-10 20:02:37 | View |
| 10-Q | Aug 4, 2026 | 2026-08-04 16:36:13 | View |
| 8-K | Aug 4, 2026 | 2026-08-04 07:09:38 | View |
Proxy statement (DEF 14A) disclosures